(Q48455443)

11 February 2018

title

HPA axis activity in multiple sclerosis correlates with disease severity, lesion type and gene expression in normal-appearing white matter (English)

1 reference

11 February 2018

0 references

2

1 reference

11 February 2018

Dick Swaab

7

1 reference

11 February 2018

Inge Huitinga

8

object named as

Inge Huitinga

1 reference

11 February 2018

author name string

Jeroen Melief

1

1 reference

11 February 2018

Corbert G van Eden

3

1 reference

11 February 2018

Charlotte Teunissen

4

1 reference

11 February 2018

Jörg Hamann

5

1 reference

11 February 2018

Bernard M Uitdehaag

6

1 reference

11 February 2018

publication date

28 June 2013

1 reference

11 February 2018

published in

Acta Neuropathologica

1 reference

11 February 2018

volume

126

1 reference

11 February 2018

issue

2

1 reference

11 February 2018

page(s)

237-249

1 reference

11 February 2018

Genetic variation influences glutamate concentrations in brains of patients with multiple sclerosis

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1140-7

Prognostic factors in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1140-7

Glucocorticoid suppression of CX3CL1 (fractalkine) by reduced gene promoter recruitment of NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1140-7

Leukemia inhibitory factor inhibits T helper 17 cell differentiation and confers treatment effects of neural progenitor cell therapy in autoimmune disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1140-7

Control of microglial neurotoxicity by the fractalkine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1140-7

Exogenous leukemia inhibitory factor stimulates oligodendrocyte progenitor cell proliferation and enhances hippocampal remyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1140-7

Cortisol is increased in postmortem cerebrospinal fluid of multiple sclerosis patients: relationship with cytokines and sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1140-7

Stress of dying is not suppressed by high-dose morphine or by dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1140-7

GluR5-mediated glutamate signaling regulates hypothalamo-pituitary-adrenocortical stress responses at the paraventricular nucleus and median eminence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1140-7

CD163-positive perivascular macrophages in the human CNS express molecules for antigen recognition and presentation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1140-7

Mood disorders and dysfunction of the hypothalamic-pituitary-adrenal axis in multiple sclerosis: association with cerebral inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1140-7

The relation between inflammation and neurodegeneration in multiple sclerosis brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1140-7

Hemolysis and cell-free hemoglobin drive an intrinsic mechanism for human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1140-7

Endocrine and immune substrates of depressive symptoms and fatigue in multiple sclerosis patients with comorbid major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1140-7

Hypothalamo-pituitary-adrenal axis activity predicts disease progression in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1140-7

Cognitive impairment correlates with hypothalamo-pituitary-adrenal axis dysregulation in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1140-7

Reduced cortisol levels in cerebrospinal fluid and differential distribution of 11beta-hydroxysteroid dehydrogenases in multiple sclerosis: implications for lesion pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1140-7

Clinical characteristics and treatment outcome in a representative sample of depressed inpatients - findings from the Munich Antidepressant Response Signature (MARS) project

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1140-7

Role of the paraventricular nucleus microenvironment in stress integration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1140-7

Local circuit regulation of paraventricular nucleus stress integration: glutamate-GABA connections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1140-7

Adrenomedullin improves the blood-brain barrier function through the expression of claudin-5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1140-7

Impaired hypothalamus-pituitary-adrenal axis activity and more severe multiple sclerosis with hypothalamic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1140-7

Astrocytes promote myelination in response to electrical impulses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1140-7

Downregulation of macrophage inhibitory molecules in multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1140-7

Identification of the haemoglobin scavenger receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1140-7

Spontaneous recovery of rats from experimental allergic encephalomyelitis is dependent on regulation of the immune system by endogenous adrenal corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1140-7

Multiple sclerosis is associated with alterations in hypothalamic-pituitary-adrenal axis function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1140-7

Primary-progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1140-7

High dose steroids in acute relapses of multiple sclerosis: MRI evidence for a possible mechanism of therapeutic effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1140-7

The neuroprotective and vasculo-neuro-regenerative roles of adrenomedullin in ischemic brain and its therapeutic potential.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1140-7

CD163: a regulated hemoglobin scavenger receptor with a role in the anti-inflammatory response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1140-7

Neither major depression nor glucocorticoid treatment affects the cellular integrity of the human hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1140-7

Late-life depressive symptoms are associated with both hyperactivity and hypoactivity of the hypothalamo-pituitary-adrenal axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1140-7

Annexin A1 and glucocorticoids as effectors of the resolution of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1140-7

Drug treatment of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1140-7

Adrenal size is increased in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1140-7

Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1140-7

Activity of the hypothalamic-pituitary-adrenal axis in multiple sclerosis: correlations with gadolinium-enhancing lesions and ventricular volume

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1140-7

Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1140-7

Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1140-7

Binding characteristics of the glucocorticoid receptor in peripheral blood lymphocytes in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1140-7

Dysregulation of the hypothalamo-pituitary-adrenal axis is related to the clinical course of MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1140-7

Concordance of psychiatric symptom ratings between a subject and informant, relevancy to post-mortem research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1140-7

Leukemia inhibitory factor is produced by myelin-reactive T cells from multiple sclerosis patients and protects against tumor necrosis factor-alpha-induced oligodendrocyte apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1140-7

Glucocorticoids induce an activated, anti-inflammatory monocyte subset in mice that resembles myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1140-7

A glucocorticoid receptor gene haplotype (TthIII1/ER22/23EK/9beta) is associated with a more aggressive disease course in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1140-7

Organization and regulation of paraventricular nucleus glutamate signaling systems: N-methyl-D-aspartate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1140-7

LIF receptor signaling limits immune-mediated demyelination by enhancing oligodendrocyte survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1140-7

10.1007/S00401-013-1140-7

21 January 2018

Identifiers

DOI

1 reference

11 February 2018

1 reference

11 February 2018